Sara Bonstein, Chief Financial Officer at INSMED Inc (INSM), sold 262,012 shares at $50.01 ($13.1M) on 2024-05-28, disclosed to the SEC on 2024-05-30.
Scheduled sale ($13.1M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.01 | 20,724 | $1.0M | 7.9% |
| 2 | $50.01 | 20,724 | $1.0M | 7.9% |
| 3 | $50.00 | 220,564 | $11.0M | 84.2% |
| Total | $50.00 avg | 262,012 | $13.1M | 100% |
| Filing → |
| INSM | SELL | 2026-02-04 | $117K | — | Filing → |
| INSM | SELL | 2026-01-08 | $809K | — | Filing → |
| INSM | SELL | 2025-07-23 | $12.0M | — | Filing → |